Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
0
Authors
Philip McCarthy
Philip McCarthy•Robert Schlossman•Charles Linker
Published
May 9, 2012
Abstract
Data are lacking on whether lenalidomide maintenance therapy prolongs the time to disease progression after autologous hematopoietic stem-cell transplantation in patients with multiple myeloma.
